Organisatie
Hematologie
Huidige onderzoekers
1 - 10 of 18 results
- Fatema Afennas (Lid)
- Veerle Beckers (Lid)
- Charlotte Caron (Lid)
- Ludwine Antoinette Claeys (Lid)
- Ann De Becker (Lid)
- Nathan De Beule (Lid)
- Inke De Haes (Lid)
- Sylvia Faict (Lid)
- Karel Fostier (Lid)
- Kristin Jochmans (Lid)
Projecten
1 - 1 of 1
- Tumor karakterisatie en ziekteopvolging in multipel myeloom door (epi) genetische typering gebruik makend van liquid biopsiesVanaf1 nov 2021 → HedenFinanciering: FWO junior postdoctoraal mandaat
Publicaties
1 - 10 van 79
- Immunomodulatory drugs: new developments(2013)
Auteurs: Karel Fostier
Pagina's: 21-28 - COVID-19, impact on myeloma patients(2020)
Auteurs: Inès Dufour, Juliette Raedemaeker, Fabio Andreozzi, Géraldine Verstraete, Sarah Bailly, Michel Delforge, Pauline Storms, Caroline Jacquy, Ann Van de Velde, Philippe Mineur, et al.
Pagina's: 1947-1949 - Haemophagocytic lymphohistiocytosis during pregnancy: a case presentation and literature review(2022)
Auteurs: Larissa Fávero Vanraes, Veerle Beckers, Kim Van Berkel, Leonardo Gucciardo, Gilles Faron
- Leptomeningeal metastasis in a marginal zone lymphoma, presenting as a delirium(2020)
Auteurs: Lisa Dreessen, Nicolas Maréchal, Michel Louisa Verheyden, Ann De Becker, Kristin Jochmans, Tim Vanderhasselt, Bert Bravenboer, Ingo Beyer
- Auto-immune hemolytic anemia and hemophagocytic lymphohistiocytosis as immune-related adverse event in patients with metastatic melanoma and concurrent chronic lymphocytic leukemia(2023)
Auteurs: Iris Dirven, An-Sofie Vander Mijnsbrugge, Sacha Mignon, Jens Tijtgat, Nicolas Kint, Bart Neyns
Pagina's: 338-344 - Improvement of transfusion practice and reduction in red blood cell utilization in Belgian hospitals(2022)
Auteurs: Jana Vanden Broeck, Katrien Beeckman, Evelyne Van Gastel, Luc De Keersmaecker, Timothy Devos, Christiane Gérard, Lucien Noens, Dominique Putzeys, Karin Van Poucke, Margareta Haelterman, et al.
Pagina's: 259-267 - Validation of a PCR-based next-generation sequencing approach for the detection and quantification of minimal residual disease in acute lymphoblastic leukemia and multiple myeloma using gBlocks as calibrators(2021)
Auteurs: Jona Van der Straeten, Wouter De Brouwer, Emmanuelle Kabongo Kanjinga, Marie-Françoise Dresse, Karel Fostier, Rik Schots, Ivan Van Riet, M.H.C. Bakkus
Pagina's: 599-611 - Mesenchymal stem cells in multiple myeloma(2018)
Auteurs: Song Xu, Kim De Veirman, Ann De Becker, Karin Vanderkerken, Ivan Van Riet
Pagina's: 1500-1514 - Discovery of Ketone-Based Covalent Inhibitors of Coronavirus 3CL Proteases for the Potential Therapeutic Treatment of COVID-19(2020)
Auteurs: Robert L Hoffman, Robert S Kania, Mary A Brothers, Jay F Davies, Rose A Ferre, Ketan S Gajiwala, Mingying He, Robert J Hogan, Kirk Kozminski, Lilian Y Li, et al.
Pagina's: 12725-12747 - A Systematic Review and Meta-Analysis of Endocrine-Related Adverse Events Associated with Immune Checkpoint Inhibitors(2019)
Auteurs: Jeroen M.K. de Filette, Corina Andreescu, Filip Cools, Bert Bravenboer, Brigitte Velkeniers-Hoebanckx
Pagina's: 145-156